Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raed Alroughani

Showing results (101-110 of 223) with videos related to

Pageof 23
Sort By:
Clinical Neurology and Neurosurgery|March 14, 2021
Real-world retrospective study of effectiveness and safety of FINgOlimod in relapsing remitting multiple sclerosis in the Middle East and North Africa (FINOMENA)Raed Alroughani, Zuhair AlKawi, Ahmed Hassan, et al.
BMC Neurology|November 25, 2016
A regional consensus recommendation on brain atrophy as an outcome measure in multiple sclerosisRaed Alroughani, Dirk Deleu, Khalid El Salem, et al.
Multiple Sclerosis International|March 22, 2021
A Prospective Multicenter Study for Assessing MusiQoL Validity among Arabic-Speaking MS Patients Treated with Subcutaneous Interferon <i>β</i>-1aMohammed Al Jumah, Suleiman Kojan, Raed Alroughani, et al.
CNS Drugs|June 24, 2021
Utilization of Multiple Sclerosis Therapies in the Middle East Over a Decade: 2009-2018Nahid Moradi, Sifat Sharmin, Charles Malpas, et al.
Neurology and Therapy|May 17, 2025
Role of Immune Reconstitution Therapy with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in Older PatientsRaed Alroughani, Jihad Inshasi, Samar Farouk, et al.
The Lancet. Neurology|March 17, 2023
Family planning considerations in people with multiple sclerosisKristen M Krysko, Ruth Dobson, Raed Alroughani, et al.
JAMA Network Open|September 28, 2022
Effect of Dimethyl Fumarate vs Interferon β-1a in Patients With Pediatric-Onset Multiple Sclerosis: The CONNECT Randomized Clinical TrialPatrick Vermersch, Matthew Scaramozza, Seth Levin, et al.
Clinical Drug Investigation|March 18, 2022
Multiple Sclerosis Relapses Following Cessation of FingolimodCharles B Malpas, Izanne Roos, Sifat Sharmin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 30, 2022
External validation of a clinical prediction model in multiple sclerosisNahid Moradi, Sifat Sharmin, Charles B Malpas, et al.
Therapeutic Advances in Neurological Disorders|April 1, 2026
Insights into adherence to cladribine tablets in the real world in multiple countries: results from patient support programsJiwon Oh, Mavis Ayer, Raed Alroughani, et al.
Pageof 23

Showing results (101-110 of 223) with videos related to

Sort By:
Pageof 23
Clinical Neurology and Neurosurgery|March 14, 2021
Real-world retrospective study of effectiveness and safety of FINgOlimod in relapsing remitting multiple sclerosis in the Middle East and North Africa (FINOMENA)Raed Alroughani, Zuhair AlKawi, Ahmed Hassan, et al.
BMC Neurology|November 25, 2016
A regional consensus recommendation on brain atrophy as an outcome measure in multiple sclerosisRaed Alroughani, Dirk Deleu, Khalid El Salem, et al.
Multiple Sclerosis International|March 22, 2021
A Prospective Multicenter Study for Assessing MusiQoL Validity among Arabic-Speaking MS Patients Treated with Subcutaneous Interferon <i>β</i>-1aMohammed Al Jumah, Suleiman Kojan, Raed Alroughani, et al.
CNS Drugs|June 24, 2021
Utilization of Multiple Sclerosis Therapies in the Middle East Over a Decade: 2009-2018Nahid Moradi, Sifat Sharmin, Charles Malpas, et al.
Neurology and Therapy|May 17, 2025
Role of Immune Reconstitution Therapy with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in Older PatientsRaed Alroughani, Jihad Inshasi, Samar Farouk, et al.
The Lancet. Neurology|March 17, 2023
Family planning considerations in people with multiple sclerosisKristen M Krysko, Ruth Dobson, Raed Alroughani, et al.
JAMA Network Open|September 28, 2022
Effect of Dimethyl Fumarate vs Interferon β-1a in Patients With Pediatric-Onset Multiple Sclerosis: The CONNECT Randomized Clinical TrialPatrick Vermersch, Matthew Scaramozza, Seth Levin, et al.
Clinical Drug Investigation|March 18, 2022
Multiple Sclerosis Relapses Following Cessation of FingolimodCharles B Malpas, Izanne Roos, Sifat Sharmin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 30, 2022
External validation of a clinical prediction model in multiple sclerosisNahid Moradi, Sifat Sharmin, Charles B Malpas, et al.
Therapeutic Advances in Neurological Disorders|April 1, 2026
Insights into adherence to cladribine tablets in the real world in multiple countries: results from patient support programsJiwon Oh, Mavis Ayer, Raed Alroughani, et al.
Pageof 23